Results 241 to 250 of about 54,679 (264)

Ipilimumab

Reactions Weekly, 2019
  +5 more sources

Ipilimumab

Reactions Weekly, 2020
openaire   +2 more sources

The foundations of immune checkpoint blockade and the ipilimumab approval decennial

Nature reviews. Drug discovery, 2021
A. Korman, Sarah C. Garrett-Thomson, N. Lonberg   +2 more
semanticscholar   +1 more source

Ipilimumab

Nature Reviews Drug Discovery, 2011
Vernon K. Sondak, Keiran S. M. Smalley, Ragini Kudchadkar, Seden Grippon, Peter Kirkpatrick   +4 more
openaire   +1 more source

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer

Cancer Cell, 2018
Matthew D Hellmann, Margaret K Callahan, Emiliano Calvo   +2 more
exaly  

Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies

Annals of Oncology, 2014
J S Weber, Bart Neyns, O Hamid
exaly  

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

Annals of Oncology, 2017
N Chaput, Patricia Lepage, L Boselli
exaly  

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Investigational New Drugs, 2010
Evan M Hersh, Steven J O'Day, Anna C Pavlick   +2 more
exaly  

An immune-active tumor microenvironment favors clinical response to ipilimumab

Cancer Immunology, Immunotherapy, 2011
Scott D Chasalow, Omid Hamid, Schmidt Henrik   +2 more
exaly  

Ipilimumab

Reactions Weekly, 2015
openaire   +2 more sources